DR. PENG(600804)2025-04-29 16:30Profit Forecast - The company expects a total profit of approximately -86,800.80 million yuan for the year 2024, with a net profit attributable to shareholders of -88,465.73 million yuan [2]. - The previous profit forecast estimated a total profit of about -69,700 million yuan and a net profit of -77,500 million yuan, indicating a significant downward revision [4]. - The company reported a total profit of -14,715.49 million yuan and a net profit of -9,324.55 million yuan for the same period last year [6]. Revenue Projections - The operating revenue for 2024 is projected to be around 187,669.45 million yuan, with the revenue after excluding non-core business income estimated at 182,025.79 million yuan [5]. Financial Position - The net assets attributable to the parent company at the end of 2024 are expected to be approximately 1,509.75 million yuan [3]. Credit Impairment - The company adjusted its credit impairment loss from an initial estimate of 12,111 million yuan to 23,269 million yuan, impacting operating profit by approximately 11,158 million yuan [7]. Delisting Risk - The company has been placed under delisting risk warning due to the negative profit forecast [2]. Investor Communication - The company acknowledges the impact of the performance forecast correction on investors and expresses sincere apologies [10]. - The company emphasizes that there are no significant disagreements with the auditing firm regarding the performance forecast correction [8]. Audit Confirmation - The financial data presented is subject to final confirmation in the audited annual report for 2024 [9].